Article
Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
JAMA - 1 Sept 2015
Tammimies Kristiina, Marshall Christian R, Walker Susan, Kaur Gaganjot, Thiruvahindrapuram Bhooma, Lionel Anath C, Yuen Ryan K C, Uddin Mohammed, Roberts Wendy, Weksberg Rosanna, Woodbury-Smith Marc, Zwaigenbaum Lonnie, Anagnostou Evdokia, Wang Zhuozhi, Wei John, Howe Jennifer L, Gazzellone Matthew J, Lau Lynette, Sung Wilson W L, Whitten Kathy, Vardy Cathy, Crosbie Victoria, Tsang Brian, D'Abate Lia, Tong Winnie W L, Luscombe Sandra, Doyle Tyna, Carter Melissa T, Szatmari Peter, Stuckless Susan, Merico Daniele, Stavropoulos Dimitri J, Scherer Stephen W, Fernandez Bridget A
Abstract excerpt
IMPORTANCE: The use of genome-wide tests to provide molecular diagnosis for individuals with autism spectrum disorder (ASD) requires more study. OBJECTIVE: To perform chromosomal microarray analysis (CMA) and whole-exome sequencing (WES) in a heterogeneous group of children with ASD to determine the molecular diagnostic yield of these tests in a sample typical of a developmental pediatric clinic. DESIGN, SETTING,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
